Litaba tsa mohala

Mokuli oa Pele o Nkoa ka Pulmonary Arterial Hypertension

ngotsoeng ke mohlophisi

Respira Therapeutics, Inc. e phatlalalitse kajeno hore mokuli oa pele United States o 'nile a lekoa tekong e mengata ea mokhethoa oa lihlahisoa tsa eona tse ka sehloohong, RT234-PAH (vardenafil e tsamaisoang e le phofshoana e omeletseng ea phekolo). Teko ea VIPAH-PRN 2b (Vardenafil Inhaled bakeng sa Pulmonary Arterial Hypertension - PRN) e tla ba le lihlopha tse peli tse latellanang tse amohelang RT234 e le tekanyo e le 'ngoe e tsamaisoang ka Axial Oscillating Sphere phofo e omileng ea inhaler. Boithuto bona bo etselitsoe ho lekola polokeho le ts'ebetso ea pele ea RT234 ho ntlafatsa ka matla matšoao a episodic le bokhoni ba boikoetliso ho batho ba alafshoang bakeng sa pulmonary arterial hypertension (PAH) le New York Heart Association (NYHA) matšoao a Functional Class II-III.     

Carol Satler, PhD, o itse: "Ho qalisoa ha teko ena ea bongaka ke mohato oa bohlokoahali bakeng sa Phefumoloho 'me ke mohato o latelang oa bohlokoa oa ho fa bakuli ba nang le PAH kalafo e matla ea ho laola phefumoloho e khuts'oane, e ba thibelang ho etsa mesebetsi e tloaelehileng ea letsatsi le letsatsi." , MD, Mopresidente le Ofisiri e ka Sehloohong ea Bongaka ea Respira. “Batho ba tšoeroeng ke boemo bona bo fokolisang le bo tebileng ba ntseng ba phekoloa ka litlhare tsa tlhokomelo ba ntse ba e-ba le linako tsa ho hema ka thata, mokhathala le ho se khone ho ikoetlisa, ’me hajoale ha ho na litlhare tsa ho qala ka potlako tse fumanehang bakeng sa tšebeliso ea ‘ha ho hlokahala’ ho fokotsa liketsahalo tsena. ”

"Ho nolofalletsa bakuli ba PAH hore ba be mafolofolo haholo ke senotlolo sa bophelo bo botle ba 'mele le ba kelello," ho boletse Raymond L. Benza, MD, Mookameli oa Division of Cardiovascular Medicine Setsing sa Bongaka sa Ohio State University Wexner. "Joale ka thuto ea RT234, re ntse re hlahloba bokhoni ba rona ba ho matlafatsa boikoetliso ba 'mele ha mokuli a bo hloka. E ka ba mohato o moholo ho ea pele ntoeng ea rona le lefu lena. ”

Teko ea VIPAH-PRN 2b (RT234-PAH-CL202) ke thuto ea ho eketseha ha lethal dose ho hlahloba liphetoho tse matla matšoao a post dosing ea RT234 ho batho ba nang le PAH. Ho nahanoa hore inhaled RT234 (vardenafil inhalation powder) e ka fana ka molemo oa phekolo bakeng sa tšebeliso e matla ho bakuli ba nang le Mokhatlo oa Lefatše oa Bophelo (WHO) Sehlopha sa 1 Pulmonary Hypertension (PH) (Pulmonary Arterial Hypertension [PAH]) ho ntlafatsa bokhoni ba boikoetliso le ts'ebetso ho mesebetsi ea bophelo ba letsatsi le letsatsi, hammoho le ho fokotsa matšoao a boikitlaetso (mohlala, dyspnea) le litlamorao tsa ona tse mpe boleng ba bophelo.

Litaba Tse Amanang

Mabapi le mongoli

mohlophisi

Mohlophisi e moholo oa eTurboNew ke Linda Hohnholz. O lula ntlong e kholo ea eTN e Honolulu, Hawaii.

Subscribe
Tsebiso ea
moeti
0 Comments
Li-feed tsa marang-rang
Sheba maikutlo ohle
0
Ke rata maikutlo a hau, ka kopo fana ka maikutlo.x
()
x
Arolelana ho...